Below is the uncorrected machine-read text of this chapter, intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text of each book. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
WILLIAM SMITH TILLETT 406 SELECTED BIBLIOGRAPHY 1923 With T. M. Rivers. Studies on varicella. The susceptibility of rabbits to the virus of varicella . J. Exp. Med. 38:673-90. 1924 With T. M. Rivers. Atypical distribution of varicella lesions dependent upon a coexistent syphilitic infection. Report of a case. Bull. Johns Hopkins Hosp. 35:137-40. With T. M. Rivers. Further observations on the phenomena encountered in attempting to transmit varicella to rabbits. J. Exp. Med. 39:777-802. With T. M. Rivers. The lesions in rabbits experimentally infected by a virus encountered in the attempted transmissions of varicella. J. Exp. Med. 40:281-87. 1925 With T. M. Rivers. Local passive immunity in the skin of rabbits to infection with (1) a filterable virus, and (2) hemolytic streptococci. J. Exp. Med. 41:185-94. 1927 Studies on immunity to pneumococcus mucosus (Type III). I. Antibody response of rabbits immunized with Type III pneumococcus. J. Exp. Med. 45:713-26. Studies on immunity to pneumococcus mucosus (Type III). II. The infectivity of Type III pneumococcus for rabbits. J. Exp. Med. 45: 1093-1106. Studies on immunity to pneumococcus mucosus (Type III). III. Increased resistance to Type III infection induced in rabbits by immunization with R and S forms of pneumococcus. J. Exp. Med. 46:343-56. 1928 Active and passive immunity to pneumococcus infection induced in rabbits by immunization with R. pneumococci. J. Exp. Med. 48:791-804.
WILLIAM SMITH TILLETT 407 1929 With O. T. Avery. Anaphylaxis with the type-specific carbohydrates of pneumococcus. J. Exp. Med. 49:251-66. With T. Francis, Jr. Cutaneous reactions to the polysaccharides and proteins of pneumococcus in lobar pneumonia. J. Exp. Med. 50:687-701. With O. T. Avery and W. F. Goebel. Chemo-immunological studies on conjugated carbohydrate- proteins. III. Active and passive anaphylaxis with synthetic sugar-proteins. J. Exp. Med. 50:551-67. 1930 With T. Francis, Jr. Serological reactions in pneumonia with a non-protein somatic fraction of pneumococcus. J. Exp. Med. 52:561-71. With T. Francis, Jr. Cutaneous reactions in pneumonia. The development of antibodies following the intradermal injection of type-specific polysaccharide. J. Exp. Med. 52:573-85. With W. F. Goebel and O. T. Avery. Chemical and immunological properties of a species-specific carbohydrate of pneumococci. J. Exp. Med. 52:895-900. 1931 With T. Francis, Jr. Cutaneous reactions in rabbits to the type-specific capsular polysaccharides of pneumococcus. J. Exp. Med. 54:587-96. 1932 With T. J. Abernethy. Serological reactions with hemolytic streptococci in acute bacterial infections. Bull. Johns Hopkins Hosp. 50: 270-86. 1933 With R. L. Garner. The fibrinolytic activity of hemolytic streptococci. J. Exp. Med. 58:485-502. 1934 With L. B. Edwards and R. L. Garner. Fibrinolytic activity of hemolytic streptococci. The development of resistance to fibrinolysis following acute hemolytic streptococcus infections. J. Clin. Invest. 13:47-78.
WILLIAM SMITH TILLETT 408 With R. L. Garner. The agglutination of hemolytic streptococci by plasma and fibrinogen. A comparison of the phenomenon to serological reactions with the same organisms. Bull. Johns Hopkins Hosp. 54:145-56. With R. L. Garner. Biochemical studies on the fibrinolytic activity of hemolytic streptococci. I. Isolation and characterization of fibrinolysin. II. Nature of the reaction. J. Exp. Med. 60:239-67. 1935 The fibrinolytic activity of hemolytic streptococci in relation to the source of strains and to cultural reactions. J. Bacteiol. 29:111-30. The occurrence of antifibrinolytic properties in the blood of patients with acute hemolytic streptococcus infections. J. Clin. Invest. 14:276-84. With T. M. Brown. Epidemic meningococcus meningitis. An analysis of twenty-six cases, twenty- one of which occurred in the spring of 1935. Bull. Johns Hopkins Hosp. 57:297-316. 1937 The bactericidal action of human serum on hemolytic streptococci. I. Observations made with serum from patients with acute infections and from normal individuals. II. Factors which influence the phenomenon in vitro. J. Exp. Med. 65:147-76. The serum treatment of pneumonia. Med. Clin. North Am. 21:148-187. With H. Southworth. Meningococcus meningitis. In International Clinics, ed. L. Hamman, pp. 9-14. Philadelphia: J. B. Lippincott Co. With C. C. Stock. The bactericidal action of human serum on hemolytic streptococci. III. Studies concerning: (1) The significance of hydrogen ion concentration in relation to the streptococcidal action of serum; (2) the effect of reducing agents on the phenomenon. J. Exp. Med. 66:617-36. Hydrogen ion concentration and anticoagulating and fibrinolytic action of cultures of streptococci and pneumococci. Proc. Soc. Exp. Biol. Med. 37:77-82. With C. C. Stock. Bactericidal action of human serum on hemolytic streptococci, active principle obtained by fractionation of sera. Proc. Soc. Exp. Biol. Med. 37:82-87.
WILLIAM SMITH TILLETT 409 1938 The fibrinolytic activity of hemolytic streptococci. Bacteriol Rev. 2: 161-216. 1940 A consideration of some of the toxic effects of sulfonamide compounds, particularly sulfapyridine. Bull. N.Y. Acad. Med. 16:217-26. 1941 With M. McCarty. The inactivating effect of sulfapyridine on the leukotoxic action of benzene. J. Exp. Med. 74:531-44. Specific antipneumococcal immunity in relation to the outcome of chemotherapy in pneumonia. Trans. Assoc. Am. Phys. 56:147-50. 1942 With M. J. Cambier and H. Dunn. Specific antipneumococcal immunity in relation to the chemotherapy of pneumonia. J. Clin. Invest. 21:511-25. 1943 With M.J. Cambier and W. H. Harris, Jr. Sulfonamide-fast pneumococci. A clinical report of two cases of pneumonia together with experimental studies on the effectiveness of penicillin and tyrothricin against sulfonamide-resistant strains. J. Clin. Invest. 22: 249-55. 1944 With M. J. Cambier and J. E. McCormack. The treatment of lobar pneumonia and pneumococcal empyema with penicillin. Bull. N.Y. Acad. Med. 20:142-78. The needs for physiological knowledge: Civilian medicine. Fed. Proc. 3:190-91. 1945 With J. E. McCormack and M. J. Cambier. The treatment of lobar pneumonia with penicillin. J. Clin. Invest. 24:589-94. With J. E. McCormack and M. J. Cambier. The use of penicillin in the local treatment of pneumococcal empyema. J. Clin. Invest. 24:595-610.
WILLIAM SMITH TILLETT 410 1948 With S. Sherry and L. R. Christensen. Presence and significance of desoxyribose nucleoprotein in the purulent pleural exudates of patients. Proc. Soc. Exp. Biol. Med. 68:179-84. With S. Sherry and L. R. Christensen. Streptococcal desoxyribonuclease: Significance in lysis of purulent exudates and production by strains of hemolytic streptococci. Proc. Soc. Exp. Biol. Med. 68:184-88. The antibiotic age. Am. J. Med. 4:159-62. 1949 With S. Sherry, L. R. Christensen, A. J. Johnson, and G. Hazlehurst. The effect in patients of streptococcal fibrinolysin (streptokinase) and streptococcal desoxyribose nuclease (streptodornase). Trans. Assoc. Am. Phys. 62:93-97. With S. Sherry. The effect in patients of streptococcal fibrinolysin (streptokinase) and streptococcal desoxyribonuclease on fibrinous, purulent, and sanguinous pleural exudations. J. Clin. Invest. 28:173-90. With S. Sherry and A. J. Johnson. The action of streptococcal desoxyribose nuclease (streptodornase), in vitro and on purulent pleural exudations of patients. J. Clin. Invest. 28:1094-1104. 1950 With S. Sherry, L. R. Christensen, A. J. Johnson, and G. Hazlehurst. Streptococcal enzymatic debridement. Ann. Surg. 131:12-22. With S. Sherry and C. T. Read. The use of streptokinase- streptodornase in the treatment of hemothorax. J. Thorac. Surg. 20:393-417. With W. N. Hubbard, Jr. Terramycin in the treatment of pneumococcal pneumonia. Ann. N.Y. Acad. Sci. 53:429-32. 1951 With S. Sherry and C. T. Read. The use of streptokinase-streptodornase in the treatment of postpneumonic empyema. J. Thorac. Surg. 21: 275-97. With S. Sherry and C. T. Read. The use of streptokinase-streptodornase in the treatment of chronic empyema. J. Thorac. Surg. 21:325-41. Prevention of rheumatic fever. Am. J. Med. 10:671-72. With S. Sherry and W. R. McCarty. Rationale of therapeutic use of streptokinase-streptodornase in amebic abscess of liver. Arch. Intern. Med. 88:752-59.
WILLIAM SMITH TILLETT 411 1952 With S. Sherry. The local use of streptokinase-streptodornase in chronic refractory areas of suppuration with draining sinuses. Ann. Surg. 135:479-88. William de Berniere MacNider. 1881-1951. Trans. Assoc. Am. Phys. 65:28-30. Studies on the enzymatic lysis of fibrin and inflammatory exudates by products of hemolytic streptococci. Harvey Lect. 45:149-210. With W. R. McCarty. Streptokinase-streptodornase in chronic infections of feet involving bones and joints. Surg. Clin. North Am. 32:405-17. With A. J. Johnson. The lysis in rabbits of intravascular blood clots by the streptococcal fibrinolytic system (streptokinase). J. Exp. Med. 95:449-64. 1953 Infectious diseases. Annu. Rev. Med. 4:1-20. 1954 With A. J. Johnson and P. R. Goger. The intravenous injection of bovine crystalline pancreatic desoxyribonuclease into patients. J. Clin. Invest. 33:1670-86. 1955 With A. J. Johnson and W. R. McCarty. The intravenous infusion of the streptococcal fibrinolytic principle (streptokinase) into patients . J. Clin. Invest. 34:169-85. 1957 With A. J. Johnson, A. P. Fletcher, and W. R. McCarty. Effects in patients of intravenous infusions of purified streptokinase preparations. Proc. Soc. Exp. Biol. Med. 94:254-58. With J. H. Ayvazian and A. J. Johnson. The use of parenterally administered pancreatic desoxyribonuclease as an adjunct in the treatment of pulmonary abscesses. Am. Rev. Tuberc. Pulm. Dis. 76:1-21. The principles involved in the topical use of streptokinase-streptodornase. Ann. N.Y. Acad. Sci. 68:151-54. With A. J. Johnson, A. P. Fletcher, and W. R. McCarty. The intravascular use of streptokinase. Ann. N.Y. Acad. Sci. 68:201-206.
WILLIAM SMITH TILLETT 412 Presidential address. From where I stand. Trans. Assoc. Am. Phys. 71:1-9. 1959 With A. J. Johnson and J. H. Ayvazian. Crystalline pancreatic desoxyribonuclease as an adjunct in the treatment of pneumococcal meningitis. N. Engl. J. Med. 260:893-900. The changing patterns of disease. Q. Bull. Northwestern Univ. Med. School 33:315-18. 1960 With H. S. Lawrence, F. T. Rapaport, and J. M. Converse. Transfer of delayed hypersensitivity to skin homografts with leukocyte extracts in man. J. Clin. Invest. 39:185-98. With H. S. Lawrence, F. T. Rapaport, and J. M. Converse. The transfer of homograft sensitivity (accelerated rejection) with DNAsetreated leukocyte extracts in man. Ann. N.Y. Acad. Sci. 87:223-30. 1962 With H. S. Lawrence, F. T. Rapaport, and J. M. Converse. Homograft sensitivity in human beings. In CIBA Foundation Symposium on Transplantation, ed. G. E. Wolstenholme and M.P. Cameron, pp. 271-81. Boston: Little Brown. With H. S. Lawrence, F. T. Rapaport, and J. M. Converse. A mechanism of homograft rejection. In Mechanism of Cell and Tissue Damage Produced by Immune Reactions, eds. P. Grabar and P. Miescher, pp. 204-209. Basel/Stuttgart: Benno Schwabe & Co. With F. T. Rapaport, H. S. Lawrence, L. Thomas, J. M. Converse, and J. Mulholland. Cross reactions to skin homografts in man. J. Clin. Invest. 41:2166-72.
WILLIAM SMITH TILLETT 413
MAURICE BOLKS VISSCHER 414
